National Taiwan University Hospital (NTUH) researchers have found a marker that could help identify people with chronic hepatitis B who are at high risk of developing liver cancer.
People with chronic hepatitis B who are in the “immune-tolerant phase” or the “inactive carrier phase” are usually not advised to take medication for treatment, as they are considered to be at low risk of developing liver cancer, NTUH attending internal medicine doctor Tseng Tai-chung (曾岱宗) told a news conference in Taipei yesterday.
However, the new indicator found using hepatitis B surface antigen quantification could more precisely determine whether these people need further treatment, Tseng said.
Photo: CNA
Hepatitis B infection is a major risk factor for liver cancer, which is the fourth-most common cancer in Taiwan, in terms of case numbers, and caused the second-highest number of cancer deaths last year.
Tseng’s team analyzed long-term follow-up data from cohort studies led by NTUH vice superintendent Kao Jia-horng (高嘉宏) and Academia Sinica academician and former vice president Chen Chien-jen (陳建仁), who is a distinguished professor in the Genomics Research Center, Academia Sinica.
Among the 6,139 people with chronic hepatitis B included in the studies, with follow-up periods of up to 20 or more years, 547 developed liver cancer.
In the first study, Tseng said his team found that non-cirrhotic inactive chronic hepatitis B carriers with serum hepatitis B surface antigen (HBsAg) levels below 100 international units per milliliter (IU/mL) had an annual liver cancer incidence of only 0.08 percent — below the internationally recommended 0.2 percent surveillance threshold.
As these people were near the benchmark, their risk of developing liver cancer was comparable to those without the disease, and therefore could be put on a more relaxed treatment follow-up schedule, he said.
However, for those with HBsAg above 100IU/mL, they could consider seeking new antiviral treatments for suppressing the antigen and reducing the risk of liver cancer, and then continue receiving routine follow-ups, he said.
The findings are significant for precision medicine and optimizing of liver cancer surveillance strategies, NTUH said.
Among inactive chronic hepatitis B carriers, about one-third had low HBsAg levels, so in areas where resources are limited, the other two-thirds with higher levels should be considered for more frequent examinations, Tseng said.
The second study found that those with chronic hepatitis B in the immune-tolerant phase with HBsAg greater than 10,000IU/mL were associated with delayed development of liver cancer, indicating that the antigen could be used as a biomarker to identify those who are truly in the low-risk, immune-tolerant phase and avoid unnecessary treatment, Tseng said.
The results were validated in a large Japanese cohort study, underscoring the diverse clinical value of surface antigen across different disease stages, NTUH said.
The results not only help redefine if someone is partially cured of hepatitis B virus and the clinical management of those in the immune-tolerant phase, but also provide strong evidence for future international treatment guidelines, it said.
The first study was published in the June edition of Gut, an international medical journal on gastroenterology and hepatology, while the second study was published in March in the medical journal Hepatology.
Three batches of banana sauce imported from the Philippines were intercepted at the border after they were found to contain the banned industrial dye Orange G, the Food and Drug Administration (FDA) said yesterday. From today through Sept. 2 next year, all seasoning sauces from the Philippines are to be subject to the FDA’s strictest border inspection, meaning 100 percent testing for illegal dyes before entry is allowed, it said in a statement. Orange G is an industrial coloring agent that is not permitted for food use in Taiwan or internationally, said Cheng Wei-chih (鄭維智), head of the FDA’s Northern Center for
The Chinese military has built landing bridge ships designed to expand its amphibious options for a potential assault on Taiwan, but their combat effectiveness is limited due to their high vulnerability, a defense expert said in an analysis published on Monday. Shen Ming-shih (沈明室), a research fellow at the Institute for National Defense and Security Research, said that the deployment of such vessels as part of the Chinese People’s Liberation Army (PLA) Navy’s East Sea Fleet signals a strong focus on Taiwan. However, the ships are highly vulnerable to precision strikes, which means they could be destroyed before they achieve their intended
About 4.2 million tourist arrivals were recorded in the first half of this year, a 10 percent increase from the same period last year, the Tourism Administration said yesterday. The growth continues to be consistent, with the fourth quarter of this year expected to be the peak in Taiwan, the agency said, adding that it plans to promote Taiwan overseas via partnerships and major events. From January to June, 9.14 million international departures were recorded from Taiwan, an 11 percent increase from the same period last year, with 3.3 million headed for Japan, 1.52 million for China and 832,962 to South Korea,
REWRITING HISTORY: China has been advocating a ‘correct’ interpretation of the victory over Japan that brings the CCP’s contributions to the forefront, an expert said An elderly Chinese war veteran’s shin still bears the mark of a bullet wound he sustained when fighting the Japanese as a teenager, a year before the end of World War II. Eighty years on, Li Jinshui’s scar remains as testimony to the bravery of Chinese troops in a conflict that killed millions of their people. However, the story behind China’s overthrow of the brutal Japanese occupation is deeply contested. Historians broadly agree that credit for victory lies primarily with the Chinese Nationalist Party (KMT)-led Republic of China (ROC) Army. Its leader, Chiang Kai-shek (蔣介石), fled to Taiwan in 1949 after losing a
RSS